MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
| Website | http://www.msinsight.tech |
| Employees | 10 (8 on RocketReach) |
| Founded | 2022 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Molecular Diagnostics, Cancer Diagnostics, Diagnostic Solutions, Oncology Testing, Clinical Diagnostics, Precision Oncology, Personalized Medicine, Genomic Testing, Genome Analysis, Genetic Testing, Medical Technology, Biomarker Discovery, Next Generation Sequencing, Health Tech, Healthcare Technology, Ngs Data Analysis, Bioinformatics, Cancer Research |
| Competitors | Microsoft, IBM, SAP, Zoho, Alteryx, Tableau, Domo, Qlik, Looker, Sisense +41 more (view full list) |
Looking for a particular MSInsight employee's phone or email?
MSInsight Questions
Arnaud Cutivet is the CEO of MSInsight.
8 people are employed at MSInsight.
MSInsight is based in Paris, Île-de-France.
Top MSInsight Employees
